The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.